Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice-Reference-Cited by-同舟云学术

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice

Published:2021-10-25 Issue:12 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Ku Min‐Wen¹,Authié Pierre¹^ORCID,Bourgine Maryline¹,Anna François¹,Noirat Amandine¹,Moncoq Fanny¹^ORCID,Vesin Benjamin¹^ORCID,Nevo Fabien¹,Lopez Jodie¹^ORCID,Souque Philippe¹,Blanc Catherine¹,Fert Ingrid¹,Chardenoux Sébastien²,Lafosse llta²,Cussigh Delphine²,Hardy David³^ORCID,Nemirov Kirill¹,Guinet Françoise⁴^ORCID,Langa Vives Francina²,Majlessi Laleh¹^ORCID,Charneau Pierre¹^ORCID

Affiliation:

1. Virology Department Institut Pasteur‐TheraVectys Joint Lab Paris France

2. Plate‐Forme Centre d'Ingénierie Génétique Murine CIGM Institut Pasteur Paris France

3. Experimental Neuropatholgy Unit Institut Pasteur Paris France

4. Lymphocytes and Immunity Unit Immunology Department Institut Pasteur Paris France

Funder

Institut Pasteur

Agence Nationale de la Recherche

H2020 Marie Skłodowska-Curie Actions

Publisher

EMBO

Subject